Smoore's 2025 first-half performance: Revenue rose 18.3% to 6.013 billion yuan, with self - brand revenue up 14.1% to 1.274 billion yuan

Aug.21
Smoore's 2025 first-half performance: Revenue rose 18.3% to 6.013 billion yuan, with self - brand revenue up 14.1% to 1.274 billion yuan
In the first half of 2025, Smoore's revenue reached 6.013 billion yuan, up by 18.3%. The adjusted net profit was 737 million yuan, down by 2.1%. The ToB business revenue was 4.739 billion yuan, up by 19.5%, while the self - brand business revenue was 1.274 billion yuan, up by 14.1%.

Key points:

 

·Overall performance:

Total revenue was 6.013 billion yuan, an increase of 18.3% year-on-year. Net profit for the period was 492 million yuan, a decrease of 28% year-on-year. Adjusted net profit was 737 million yuan, a slight decrease of 2.1% year-on-year.

 

·Performance of business segments:

Total revenue from ToB business reached 4.739 billion RMB, a year-on-year increase of 19.5%. Revenue from proprietary brand businesses amounted to 1.274 billion RMB, representing a 14.1% increase compared to the previous year.

 

·Regional market performance:

Europe and other countries: Revenue of RMB 2.734 billion, a year-on-year increase of 38%. U.S. market: Revenue of RMB 1.888 billion, a year-on-year increase of 1.5%. Mainland China: Revenue of RMB 0.117 billion, a year-on-year decrease of 6.1%.

 

·New business highlights:

HNB products: Support strategic clients to launch high-end series in the Japanese market and plan nationwide promotion in September. Special purpose atomization and medical, beauty business: Revenue of Lanmei beauty device reached 31 million RMB, a year-on-year increase of 2595%.

 

·Research and Development investment:

Research and development expenditures: 723 million RMB, a decrease of 4.9% year-on-year. Future direction: Focus on HNB and atomized medical sector.

 


 

According to a message from Smoore's official website on August 20th, Smoore International (06969.HK) announced its performance for the first half of 2025: the group achieved revenue of approximately RMB 6.013 billion, an 18.3% increase year-on-year; net profit for the period was approximately RMB 492 million, a 28% decrease year-on-year; excluding non-cash expenses such as share-based payments, adjusted net profit was approximately RMB 737 million, a slight decrease of 2.1% year-on-year.

 

Among them, the revenue of ToB business reached 4.739 billion yuan, a year-on-year increase of 19.5%, mainly driven by the increasing demand for compliant products following the European market's ban on disposable electronic cigarettes. The revenue of the self-owned brand business reached approximately 1.274 billion yuan, representing a year-on-year increase of 14.1%.

 

By region, revenue (ToB) in Europe and other countries increased by 38% year-on-year to 27.34 billion yuan, revenue (ToB) in the US market was approximately 18.88 billion yuan, a year-on-year growth of 1.5%, and revenue (ToB) in mainland China decreased by about 6.1% year-on-year to 1.17 billion yuan.

 

Smoore stated that in the HNB (Heat-Not-Burn) product field, the group has supported strategic clients in launching high-end series in the Japanese market and plans to promote nationwide in September; the special purpose atomization and medical, beauty business continue to advance, with the revenue of the Lan Zhi beauty instrument reaching 310 million yuan, a year-on-year increase of 2595%.

 

In addition, Smoore's research and development expenses were 723 million yuan, a decrease of 4.9% from the previous year, with a focus on HNB and atomization medical directions in the future.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Australia TGA Warns Delivery Platforms: Don’t Promote or Supply Vapes Illegally
Australia TGA Warns Delivery Platforms: Don’t Promote or Supply Vapes Illegally
The Therapeutic Goods Administration (TGA) warned online delivery platforms not to breach Australian vape laws and said it worked with two major companies to remove non-compliant material. Under the Therapeutic Goods Act 1989, advertising vapes to the public is banned and sales are pharmacy-only; tobacconists and convenience stores cannot supply vapes. TGA will continue enforcement, with severe penalties for breaches.
Oct.30 by 2FIRSTS.ai
Euromonitor: RRP Market Reaches $74 Billion, Accounting for 12.7% of Global Nicotine Industry as Five Key Trends Drive Transformation
Euromonitor: RRP Market Reaches $74 Billion, Accounting for 12.7% of Global Nicotine Industry as Five Key Trends Drive Transformation
In 2025, global tobacco leaf production surged, but prices stagnated as climate change intensified farming risks. 2Firsts reports from the ITGA meeting, revealing structural challenges and transition pressures in the industry.
Sep.29
Special Report | After the Shortage: How the U.S. Vape Market Is Rebuilding Itself
Special Report | After the Shortage: How the U.S. Vape Market Is Rebuilding Itself
After a wave of regulatory crackdowns, the U.S. vaping market is undergoing a deep reshuffle — shortages sparked frenzy, and resupply triggered elimination. Through interviews with industry insiders from both China and the United States, 2Firsts reveals how the American market is rebuilding itself amid turbulence.
Nov.12
Morocco Lawmakers Propose Excise Taxes on Vapes, Hookah, and Nicotine Alternatives
Morocco Lawmakers Propose Excise Taxes on Vapes, Hookah, and Nicotine Alternatives
Members of the Socialist Union of Popular Forces (USFP) have submitted amendments to Article 7 of the Finance Bill, introducing new excise taxes on e-cigarette liquids, hookah accessories, and non-tobacco nicotine products. The proposal also revises VAT exemptions and insurance tax rates to enhance fiscal fairness and revenue clarity.
Nov.11 by 2FIRSTS.ai
Product | ELFBAR Launches New Open-System Device in UK with Three Pod Options and 2800mAh Battery
Product | ELFBAR Launches New Open-System Device in UK with Three Pod Options and 2800mAh Battery
ELFBAR has launched its new open-system device ELFX MEGA, compatible with 2 mL, 5 mL and 10 mL pods and equipped with a 2800mAh battery that delivers significantly longer runtime than its predecessor. The device has passed MHRA notification in the UK and is now available online in the UK at a retail price of around £18.99.
Nov.25 by 2FIRSTS.ai
Congress Calls on FDA to Allocate at Least $200 Million for ENDS Enforcement, Multi-Agency Task Force to Target Illegal e-Cigarette Imports. IKE Tech and Ispire Utilize Blockchain and Age Verification Technology to Support Regulation, Submit Chips as Part
Congress Calls on FDA to Allocate at Least $200 Million for ENDS Enforcement, Multi-Agency Task Force to Target Illegal e-Cigarette Imports. IKE Tech and Ispire Utilize Blockchain and Age Verification Technology to Support Regulation, Submit Chips as Part
Congress demands FDA allocate at least $200 million for ENDS enforcement; multi-agency task force to combat illegal e-cigarette imports.
Nov.18 by 2FIRSTS.ai